Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Rosebank Industries NPV (Reg S) (ROSE) by William Kay in The Times - Tempus
- Buy Vistry Group (VTY) by Stephen Wright in The Motley Fool
- Sell Surface Transforms (SCE) by Steve Moore in ShareProphets
- Avoid Greggs (GRG) by Steve Moore in ShareProphets
- Sell Altona Rare Earths (REE) by Hot Stock Rockets in ShareProphets
- Avoid Globaldata (DATA) by Steve Moore in ShareProphets
- Buy Standard Life plc (SDLF) by Simon Watkins in The Motley Fool
- Avoid Bunzl (BNZL) by Steve Moore in ShareProphets
- Buy Eco buildings Group (ECOB) by Hot Stock Rockets in ShareProphets
- Buy Abrdn (ABDN) by Andrew Mackie in The Motley Fool
- Buy BAE Systems (BA.) by Goldman Sachs
- Hold M&G (MNG) by Simon Watkins in The Motley Fool
- Avoid Safestay (SSTY) by Steve Moore in ShareProphets
- Buy Rolls-Royce Holdings (RR.) by Simon Watkins in The Motley Fool
- Buy Fresnillo (FRES) by Andrew Mackie in The Motley Fool
- Neutral Tate & Lyle (TATE) by UBS
- Neutral HSBC Holdings (HSBA) by UBS
- Buy Keller Group (KLR) by Berenberg
- Buy National Grid (NG.) by Goldman Sachs
- Buy Inchcape (INCH) by Berenberg
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,440 open tips for GSK (GSK)
| Latest Bid : 2,128.00p | Latest Ask : 2,130.00p |
| High Today : 2,131.00p | Low Today : 2,105.00p |
| This Years High : 2,268.00p | This Years Low : 1,264.00p |
| Volume : 504,769 | MKT Cap : £88288.5M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Neutral | Citi | Premium Only | 2026-01-27 05:32:00 27/01/2026 | – |
| Neutral | UBS | Premium Only | 2026-01-23 13:01:00 23/01/2026 | – |
| Add | Simon Watkins | Premium Only | 2026-01-20 15:00:00 20/01/2026 | 19.58% |
| Neutral | UBS | Premium Only | 2026-01-16 08:58:00 16/01/2026 | – |
| Hold | Deutsche Bank | Premium Only | 2026-01-16 07:11:00 16/01/2026 | 15.78% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Millennium International Management LP | 0.51% | 22/01/2026 |
| Latest Bid : 2,128.00p | Latest Ask : 2,130.00p |
| High Today : 2,131.00p | Low Today : 2,105.00p |
| This Years High : 2,268.00p | This Years Low : 1,264.00p |
| Volume : 504,769 | MKT Cap : £88288.5M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Neutral | Citi | Premium Only | 2026-01-27 05:32:00 27/01/2026 | – |
| Neutral | UBS | Premium Only | 2026-01-23 13:01:00 23/01/2026 | – |
| Add | Simon Watkins | Premium Only | 2026-01-20 15:00:00 20/01/2026 | 19.58% |
| Neutral | UBS | Premium Only | 2026-01-16 08:58:00 16/01/2026 | – |
| Hold | Deutsche Bank | Premium Only | 2026-01-16 07:11:00 16/01/2026 | 15.78% |